Viewing Study NCT05154994


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2025-12-26 @ 1:20 AM
Study NCT ID: NCT05154994
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2021-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module